Home › Funds › VESTOR CAPITAL, LLC › IBRX
VESTOR CAPITAL, LLC position in IBRX
IMMUNITYBIO INC · Health Care
VESTOR CAPITAL, LLC reported holding 44,835 shares of IBRX (IMMUNITYBIO INC) in its Q2 2026 13F filing — a position valued at US$12.1M, representing 0.77% of its reported portfolio and ranking #37 among its reported holdings. VESTOR CAPITAL, LLC has disclosed IBRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How VESTOR CAPITAL, LLC's IBRX position evolved
VESTOR CAPITAL, LLC first disclosed a stake in IBRX in Q1 2026 at 11,536 shares (US$88K). The position peaked in Q2 2026 at 44,835 shares, worth US$12.1M. Across 2 filings, VESTOR CAPITAL, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 44,835 shares valued at US$12.1M — an increase of 33,299 shares quarter over quarter.. Notable position changes include a 289% increase in Q2 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 11.54K | $88.00K | New |
| Q2 2026 | 44.84K | $12.05M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IBRX and 13F data
IBRX (IMMUNITYBIO INC) is a Health Care company. 68 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), Sound Capital Solutions LLC (US$9.8M), Clearwater Capital Advisors, LLC (US$6.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IBRX
- GREAT POINT PARTNERS LLC 3.00M sh · $26.27M · Q2 2026
- Sound Capital Solutions LLC 1.12M sh · $9.81M · Q2 2026
- Clearwater Capital Advisors, LLC 717.52K sh · $6.28M · Q2 2026
- ALLEN HOLDING INC /NY 687.57K sh · $6.02M · Q2 2026
- Kercheville Advisors, LLC 613.38K sh · $5.79M · Q3 2026
- SHEETS SMITH WEALTH MANAGEMENT 512.57K sh · $4.84M · Q3 2026
- Legacy Capital Group California, Inc. 446.00K sh · $3.90M · Q2 2026
- MOR Wealth Management, LLC 302.45K sh · $2.65M · Q2 2026
- NIA IMPACT ADVISORS, LLC 270.17K sh · $2.37M · Q2 2026
More on VESTOR CAPITAL, LLC
FAQ
How long has VESTOR CAPITAL, LLC held IBRX?
VESTOR CAPITAL, LLC has disclosed IBRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is VESTOR CAPITAL, LLC's current position in IBRX?
As of Q2 2026, VESTOR CAPITAL, LLC holds 44.84K shares of IBRX (IMMUNITYBIO INC), valued at $12.05M, representing 0.77% of its reported portfolio and ranking #37.
Has VESTOR CAPITAL, LLC been buying or selling IBRX?
In the latest 13F filing (Q2 2026), VESTOR CAPITAL, LLC increased its position in IBRX. The position peaked in Q2 2026 at 44.84K shares.
Which other funds hold IBRX?
Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, Sound Capital Solutions LLC, Clearwater Capital Advisors, LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.